Comprehensive care of the patient with haemophilia and inhibitors undergoing surgery: Practical aspects

Haemophilia

Volumn 19, Issue 1, 2013, Pages 2-10

  Kulkarni, R ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Activated prothrombin complex concentrate; Comprehensive health care; Haemophilia; Inhibitors; Recombinant activated FVII; Surgery

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

CONGENITAL HEMOPHILIA WITH INHIBITOR; DRUG MEGADOSE; ELECTIVE SURGERY; HEMOPHILIA; HUMAN; MEDLINE; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

BLOOD COAGULATION FACTOR INHIBITORS; COAGULANTS; COMPREHENSIVE HEALTH CARE; FACTOR IX; FACTOR VIII; HEMOPHILIA A; HEMOPHILIA B; HEMORRHAGE; HUMANS; INTERDISCIPLINARY COMMUNICATION; PERIOPERATIVE CARE; SURGICAL PROCEDURES, OPERATIVE;

EID: 84871019265     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2012.02922.x     Document Type: Review

References (60)

1. Coppola A, Di Capua M, Di Minno MN et al. Treatment of hemophilia: a review of current advances and ongoing issues. J Blood Med 2010; 1: 183-95.
2. Smith PS, Levine PH; Centers at DoEPH. The benefits of comprehensive care of hemophilia: a five-year study of outcomes. Am J Public Health 1984; 74: 616-7.
3. Soucie JM, Nuss R, Evatt B et al. Mortality among males with hemophilia: relations with source of medical care. Blood 2000; 96: 437-42.
4. DiMichele D. Inhibitors in Hemophilia: A Primer. Treatment of Hemophilia, April 2008, No. 7. Montreal, Quebec: World Federation of Hemophilia, 2008. Available at: http://www1.wfh.org/publication/files/pdf-1122.pdf. Accessed June 22, 2012.
5. Valentino LA, Cooper DL, Goldstein B. Surgical experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factor VIII or IX. Haemophilia 2011; 17: 579-89.
6. Rodriguez-Merchan EC, Jimenez-Yuste V, Gomez-Cardero P, Alvarez-Roman M, Martin-Salces M, Rodriguez de la Rua A. Surgery in haemophilia patients with inhibitors, with special emphasis on orthopaedics: Madrid experience. Haemophilia 2010; 16: 84-8.
7. Mauser-Bunschoten E, Roosendaal G, Schutgens R, Fischer K. Comorbidity in the aging haemophilia patient. Haemophilia 2008; 14: 128. Abstract 22 PO 07.
8. Teitel JM, Carcao M, Lillicrap D et al. Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care. Haemophilia 2009; 15: 227-39.
9. Aouba A, Dezamis E, Sermet A et al. Uncomplicated neurosurgical resection of a malignant glioneural tumour under haemostatic cover of rFVIIa in a severe haemophilia patient with a high-titre inhibitor: a case report and literature review of rFVIIa use in major surgeries. Haemophilia 2010; 16: 54-60.
10. Quintana-Molina M, Martinez-Bahamonde F, Gonzalez-Garcia E et al. Surgery in haemophilic patients with inhibitor: 20 years of experience. Haemophilia 2004; 10: 30-40.
11. Shapiro A, Cooper DL, U. S. survey of surgical capabilities experience with surgical procedures in patients with congenital haemophilia with inhibitors. Haemophilia 2012; 18: 400-5.
12. Sheth S, DiMichele D, Lee M et al. Heart transplant in a factor VIII-deficient patient with a high-titre inhibitor: perioperative management using high-dose continuous infusion factor VIII and recombinant factor VIIa. Haemophilia 2001; 7: 227-32.
13. Giangrande PL, Wilde JT, Madan B et al. Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors. Haemophilia 2009; 15: 501-8.
14. Wiedel J, Stabler S, Geraghty S, Funk S. Joint Replacement Surgery in Hemophilia. Treatment of Hemophilia, June 2010, No. 50. Montreal, Quebec: World Federation of Hemophilia, 2010. Available at: http://www1.wfh.org/publication/files/pdf-1210.pdf. Accessed June 22, 2012.
15. Solimeno LP, Mancuso ME, Pasta G, Santagostino E, Perfetto S, Mannucci PM. Factors influencing the long-term outcome of primary total knee replacement in haemophiliacs: a review of 116 procedures at a single institution. Br J Haematol 2009; 145: 227-34.
16. Durkin MT, Mercer KG, McNulty MF et al. Vascular surgical society of Great Britain and Ireland: contribution of malnutrition to postoperative morbidity in vascular surgical patients. Br J Surg 1999; 86: 702.
17. Rodriguez-Merchan EC. Surgical wound healing in bleeding disorders. Haemophilia 2012; 18: 487-90.
18. Rajpurkar M, Boldt-Macdonald K, McLenon R et al. Ethanol lock therapy for the treatment of catheter-related infections in haemophilia patients. Haemophilia 2009; 15: 1267-71.
19. Crnich CJ, Halfmann JA, Crone WC, Maki DG. The effects of prolonged ethanol exposure on the mechanical properties of polyurethane and silicone catheters used for intravascular access. Infect Control Hosp Epidemiol 2005; 26: 708-14.
20. Aryal KR, Wiseman D, Siriwardena AK, Bolton-Maggs PHB, Hay CRM, Hill J. General surgery in patients with a bleeding diathesis: how we do it. World J Surg 2011; 35: 2603-10.
21. Shibata M, Nakagawa T, Akioka S et al. Hemostatic treatment using factor VIII concentrates for neutralizing high-responding inhibitors prior to CVAD insertion for immune-tolerance induction therapy. Clin Appl Thromb Hemost 2012; 18: 66-71.
22. Negrier C, Goudemand J, Sultan Y, Bertrand M, Rothschild C, Lauroua P. Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors French FEIBA Study Group. Factor Eight Bypassing Activity. Thromb Haemost 1997; 77: 1113-9.
23. Lopez-Vilchez I, Hedner U, Altisent C, Diaz-Ricart M, Escolar G, Galan AM. Redistribution and hemostatic action of recombinant activated factor VII associated with platelets. Am J Pathol 2011; 178: 2938-48.
24. Kulkarni R, Aledort LM, Berntorp E et al. Therapeutic choices for patients with hemophilia and high-titer inhibitors. Am J Hematol 2001; 67: 240-6.
25. Mathews V, Nair SC, David S, Viswabandya A, Srivastava A. Management of hemophilia in patients with inhibitors: the perspective from developing countries. Semin Thromb Hemost 2009; 35: 820-6.
26. Prabhu R, Jijina F, Shetty S, Ghosh K. Successful surgery in severe haemophilia - a two-stage replacement therapy in resource-poor countries. Haemophilia 2008; 14: 1125-6.
27. Balkan C, Karapinar D, Aydogdu S et al. Surgery in patients with haemophilia and high responding inhibitors: Izmir experience. Haemophilia 2010; 16: 902-9.
28. Boadas A, Fernandez-Palazzi F, De Bosch NB, Cedeno M, Ruiz-Saez A. Elective surgery in patients with congenital coagulopathies and inhibitors: experience of the National Haemophilia Centre of Venezuela. Haemophilia 2011; 17: 422-7.
29. Caviglia H, Candela M, Galatro G, Neme D, Moretti N, Bianco RP. Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature. Haemophilia 2011; 17: 910-9.
30. Ingerslev J. Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors. Semin Thromb Hemost 2000; 26: 425-32.
31. Takedani H, Kawahara H, Kajiwara M. Major orthopaedic surgeries for haemophilia with inhibitors using rFVIIa. Haemophilia 2010; 16: 290-5.
32. Obergfell A, Auvinen MK, Mathew P. Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: a review of the literature. Haemophilia 2008; 14: 233-41.
33. Rodriguez-Merchan EC, Rocino A, Ewenstein B et al. Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statement. Haemophilia 2004; 10(Suppl. 2): 50-2.
34. Caviglia H, Narayan P, Forsyth A et al. Musculoskeletal problems in persons with inhibitors: how do we treat? Haemophilia 2012; 18(Suppl. 4): 54-60.
35. Kraut EH, Aledort LM, Arkin S, Stine KC, Wong WY. Surgical interventions in a cohort of patients with haemophilia A and inhibitors: an experiential retrospective chart review. Haemophilia 2007; 13: 508-17.
36. Lauroua P, Ferrer AM, Guerin V. Successful major and minor surgery using factor VIII inhibitor bypassing activity in patients with haemophilia A and inhibitors. Haemophilia 2009; 15: 1300-7.
37. ® for surgeries in patients with inhibitors. Haemophilia 2011; 17: 28-34.
38. Tjonnfjord GE. Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX: the updated Norwegian experience. Haemophilia 2004; 10: 41-5.
39. Zülfikar B, Aydogan G, Salcioglu Z et al. Efficacy of FEIBA for acute bleeding and surgical haemostasis in haemophilia A patients with inhibitors: a multicentre registry in Turkey. Haemophilia 2012; 18: 383-91.
40. Ingerslev J, Sorensen B. Parallel use of by-passing agents in haemophilia with inhibitors: a critical review. Br J Haematol 2011; 155: 256-62.
41. Dargaud Y, Lienhart A, Negrier C. Prospective assessment of thrombin generation test for dose monitoring of bypassing therapy in hemophilia patients with inhibitors undergoing elective surgery. Blood 2010; 116: 5734-7.
42. Pivalizza EG, Escobar MA. Thrombelastography-guided factor VIIa therapy in a surgical patient with severe hemophilia and factor VIII inhibitor. Anesth Analg 2008; 107: 398-401.
43. Escobar MA. Recombinant factor VIIa: the possibilities for monitoring. Transfus Altern Transfus Med 2003; 5: 51-4.
44. ®)) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A - a two-centre experience. Haemophilia 2012; 18: 544-9.
45. Slaoui M, Lambert T, Stieltjes N, Claeyssens S, Borel-Derlon A; Study Group. Intestinal surgery with activated recombinant factor VII prophylaxis in patients with haemophilia A and high responding inhibitors: a report of five cases. Blood Coagul Fibrinolysis 2004; 15: 687-91.
46. Jimenez-Yuste V, Rodriguez-Merchan EC, Alvarez MT, Quintana M, Fernandez I, Hernandez-Navarro F. Controversies and challenges in elective orthopedic surgery in patients with hemophilia and inhibitors. Semin Hematol 2008; 45: S64-7.
47. Choi S, Brull R. Neuraxial techniques in obstetric and non-obstetric patients with common bleeding diatheses. Anesth Analg 2009; 109: 648-60.
48. Sripada R, Reyes JJ, Sun R. Peripheral nerve blocks for intraoperative management in patients with hemophilia A. J Clin Anesth 2009; 21: 120-3.
49. Mannucci PM, Schutgens REG, Santagostino E, Mauser-Bunschoten EP. How I treat age-related morbidities in elderly persons with hemophilia. Blood 2009; 114: 5256-63.
50. Philipp C. The aging patient with hemophilia: complications, comorbidities, and management issues. Hematology Am Soc Hematol Educ Program 2010; 2010: 191-6.
51. Ludlam C. Identifying and managing inhibitor patients requiring orthopaedic surgery - the multidisciplinary team approach. Haemophilia 2005; 11: 7-10.
52. Konkle BA, Nelson C, Forsyth A, Hume E. Approaches to successful total knee arthroplasty in haemophilia A patients with inhibitors. Haemophilia 2002; 8: 706-10.
53. Solimeno LP, Perfetto OS, Pasta G, Santagostino E. Total joint replacement in patients with inhibitors. Haemophilia 2006; 12: 113-6.
54. Kempton CL, White GC. How we treat a hemophilia A patient with a factor VIII inhibitor. Blood 2009; 113: 11-7.
55. Mannucci PM, Mauser-Bunschoten EP. Cardiovascular disease in haemophilia patients: a contemporary issue. Haemophilia 2010; 16: 58-66.
56. Lison S, Spannagl M, Dietrich W; Working Group of Perioperative Hemostasis. Hemophilia A in cardiac operations: a model of reduced thrombin generation. Ann Thorac Surg 2011; 91: 1606-8.
57. Jones AE, Roy A, Armstrong T, Rees M, Welsh FK. Successful liver surgery in a haemophilia patient with high titre factor VIII inhibitor. Haemophilia 2009; 15: 1332-3.
58. DiMichele DM, Mirani G, Wilfredo Canchis P, Trost DW, Talal AH. Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection. Haemophilia 2003; 9: 613-8.
59. Hoots WK. Emergency Care Issues in Hemophilia. Treatment of Hemophilia, November 2007, No. 43. Montreal, Quebec: World Federation of Hemophilia, 2007. Available at: http://www1.wfh.org/publication/files/pdf-1196.pdf. Accessed June 22, 2012.
60. Rodriguez-Merchan EC. Aspects of current management: orthopaedic surgery in haemophilia. Haemophilia 2012; 18: 8-16.